Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study will evaluate the long-term real-world safety of xanomeline-trospium chloride in adults with schizophrenia receiving routine clinical care in the United States.
Epistemonikos ID: 47e5c3bb2a5796a3ed57debe08288eb24e5b5ff1
First added on: Aug 25, 2026